nanodevice formulation irinotecan metabolite polymeric micelle constructed covalently attaching block copolymer pegpglu followed selfassembly amphiphilic block copolymers aqueous completed phase ii clinical trials triplenegative breast cancer relapsed small cell lung nippon kayaku received orphan drug designation us means approved united states nippon kayaku entitled years market exclusivity intended incentivize future development mean drug approvedcitation needed antineoplastic immunomodulatory drug article stub help wikipedia expanding